Posts By :

Deborah L. Ungerleider, MD, FAAP

Is There a Role for D-Mannose, Cranberry or Probiotics in Preventing Pediatric UTIs?
Is There a Role for D-Mannose, Cranberry or Probiotics in Preventing Pediatric UTIs? 1024 683 Deborah L. Ungerleider, MD, FAAP

Alternatives for prophylaxis of UTIs in children may help reduce antibiotic overuse. Preventing urinary tract infections (UTIs) in children is important, as multiple UTIs can lead to scarring of the kidneys, which can then lead to hypertension or end-stage renal disease.1 UTIs in children are generally treated with antibiotics, which are sometimes also used for…

The Success of an EMR-Based Health-Related Social Needs Screen in Pediatrics
The Success of an EMR-Based Health-Related Social Needs Screen in Pediatrics 1024 683 Deborah L. Ungerleider, MD, FAAP

Standardized universal HRSN screening with an EMR system and follow-up by social work consults can be successful and contribute to reducing health disparities.   Health-related social needs (HRSNs), sometimes referred to as social determinants of health (SODH), are the risk factors of food insecurity, lack of stable housing and poverty, all of which can play…

Making Exercise Part of Your Treatment Plan: Play Strong for Children With ASD
Making Exercise Part of Your Treatment Plan: Play Strong for Children With ASD 150 150 Deborah L. Ungerleider, MD, FAAP

How can clinicians use exercise in their treatment of behavioral and mental health disorders? Experts share lessons learned from the Play Strong program.   It is well-known in the medical world that exercise is good for the mind and body, both for children and adults. However, although health care providers may recommend that exercise be…

Treating Intrauterine Opioid Exposure in Infants Born Preterm
Treating Intrauterine Opioid Exposure in Infants Born Preterm 1024 575 Deborah L. Ungerleider, MD, FAAP

We need a protocol to evaluate and treat neonatal abstinence syndrome in preterm infants. Neonatal abstinence syndrome (NAS) occurs when infants who are exposed to opioids in utero develop withdrawal signs and symptoms after birth.1 According to past studies, NAS occurs in 55% to 94% of infants exposed to opioids, with an increasing incidence between…